ALIF-B.ST
ALIF-B.ST
SE0014401378
AddLife AB ser. B
Loading chart...

Company Profile

AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis. It offers products and solutions, including analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical services; and in the areas of microbiology, clinical chemistry, coagulation, molecular biology, research, immunology, point-of-care testing, veterinary diagnostics, as well as in the food industry. This segment also provides training programs for its customers. The Medtech segment provides medical device products for surgery, orthopaedics, critical care, endoscopy, wound care, healthcare IT, ophthalmology, home adaptation, and technical aids, as well as surgical procedures, welfare technology, and assistive devices for the elderly and disabled. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, Poland, Austria, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.

Related stocks

OBCK.DE
OBCK.DE • Germany
Ottobock SE & Co. KGaA I
53.2 EUR
3.81B USD
AFX.DE
AFX.DE • Germany
Carl Zeiss Meditec AG I
32.42 EUR
3.18B USD 1Y -30.7%
DYVOX.ST
DYVOX.ST • Sweden
Dynavox Group AB
82.8 SEK
878.75M USD 1Y -24.8%
BONEX.ST
BONEX.ST • Sweden
BONESUPPORT HOLDING AB
237.2 SEK
1.55B USD 1Y -13%
SKAN.SW
SKAN.SW • Switzerland
SKAN N
70.7 CHF
1.92B USD 1Y +22.5%
TECN.SW
TECN.SW • Switzerland
TECAN GROUP AG N
235 CHF
3.49B USD 1Y +55.4%
1SXP.DE
1SXP.DE • Germany
SCHOTT Pharma AG & Co. KGaA I
23.5 EUR
3.97B USD 1Y +20%
SYNSAM.ST
SYNSAM.ST • Sweden
Synsam AB
51.7 SEK
727.36M USD 1Y -12.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
47.5% p.a.
Max Drawdown (5Y)
-85.5%
Sharpe Ratio (5Y)
-0.30
Beta Factor
1.52
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
High market risk: Beta of 1.52 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (47.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -85.6% in the extended horizon.
ende